3 articles | last updated: Aug 2 11:16:55
Large-scale study of 46 million adults in England shows significant drop in cardiovascular events post-vaccination.
- Heart attacks and strokes decreased by up to 10% after the first vaccine dose.
- Reductions of up to 27% for AstraZeneca and 20% for Pfizer were observed after the second dose.
- The study confirmed the overall cardiovascular safety of COVID-19 vaccines.
- Rare side effects like myocarditis and blood clots were noted but were outweighed by benefits.
- Researchers used comprehensive health records from nearly the entire adult population of England.
People, Places and Things In This Story
- England UK constituent country
- AstraZeneca Pharmaceutical industry company
- Pfizer Pharmaceutical industry company
Categories:
- Health
- Science